0001209191-21-031481.txt : 20210511
0001209191-21-031481.hdr.sgml : 20210511
20210511085827
ACCESSION NUMBER: 0001209191-21-031481
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210507
FILED AS OF DATE: 20210511
DATE AS OF CHANGE: 20210511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Jatin
CENTRAL INDEX KEY: 0001782186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 21909810
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS, INC.
STREET 2: 85 WELLS AVENUE
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-07
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001782186
Shah Jatin
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVE.
NEWTON
MA
02459
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2021-05-07
4
P
0
23250
8.6018
A
131802
D
Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $8.5850 to $8.61, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 861 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2021.
/s/ Nancy Smith as Attorney-in-Fact for Jatin Shah
2021-05-11